Jin, X., Lin, T., Yang, G., Cai, H., Tang, B., Liao, X., . . . Li, H. (2020). Use of Tregs as a cell‐based therapy via CD39 for benign prostate hyperplasia with inflammation. J Cell Mol Med.
Citação norma ChicagoJin, Xi, et al. "Use of Tregs As a Cell‐based Therapy Via CD39 for Benign Prostate Hyperplasia With Inflammation." J Cell Mol Med 2020.
MLA CitationJin, Xi, et al. "Use of Tregs As a Cell‐based Therapy Via CD39 for Benign Prostate Hyperplasia With Inflammation." J Cell Mol Med 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.